Your browser doesn't support javascript.
loading
Protocol for generation of humanized HCC mouse model and cancer-driver mutations using CRISPR-Cas9.
Zhu, Yicheng; Tahara, Stanley M; Tsukamoto, Hidekazu; Machida, Keigo.
Afiliación
  • Zhu Y; Departments of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, Los Angeles, CA, USA.
  • Tahara SM; Departments of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, Los Angeles, CA, USA.
  • Tsukamoto H; Departments of Pathology, University of Southern California, Los Angeles, Los Angeles, CA, USA; Southern California Research Center for ALPD and Cirrhosis, Los Angeles, CA, USA.
  • Machida K; Departments of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, Los Angeles, CA, USA; Southern California Research Center for ALPD and Cirrhosis, Los Angeles, CA, USA. Electronic address: keigo.machida@med.usc.edu.
STAR Protoc ; 4(4): 102389, 2023 Dec 15.
Article en En | MEDLINE | ID: mdl-38103196
ABSTRACT
We detail procedures for generating a humanized mouse model of hepatocellular carcinoma (HCC) recapitulating genetic mutations associated with metabolic liver diseases (MLD). We humanized liver parenchymal, non-parenchymal, and hematopoietic cells. We employed CRISPR-Cas9-based ARID1A knockout and constitutively active CTNNB1 knockin combined with an alcohol Western diet to generate cancer-driver mutations commonly found in MLD-HCC patients. This HCC model facilitates the study of tumor-promoting gene-environment interactions. For complete details on the use and execution of this protocol, please refer to Yeh et al.1.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: STAR Protoc Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: STAR Protoc Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...